ArticleMedical science monitor : international medical journal of experimental and clinical research2022

Editorial: First Approval of the Protein-Based Adjuvanted Nuvaxovid (NVX-CoV2373) Novavax Vaccine for SARS-CoV-2 Could Increase Vaccine Uptake and Provide Immune Protection from Viral Variants.

Dinah V ParumsPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.